Ayo-Ajibola Oluwatobiloba O, Koh Michelle, Julien Catherine, Davis Ryan J, Lin Matthew E, Kim James, Mack Wendy J, Kwon Daniel I
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Head and Neck Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.
Otolaryngol Head Neck Surg. 2025 Feb;172(2):517-530. doi: 10.1002/ohn.1041. Epub 2024 Nov 4.
Human papillomavirus (HPV) is a significant driver of elevated risk for oropharyngeal squamous cell carcinoma (OPSCC). In 2018, HPV vaccination eligibility was expanded to men and women aged 27 to 45. We evaluated changes in awareness of HPV, its association with OPSCC, and HPV vaccination among all US adults between 2018 and 2020, focusing on those aged 27 to 45.
Cross-sectional survey cycles.
The Health Information National Trends Survey (HINTS).
The HINTS, a nationally representative survey of US adults, was queried. A total of 3504 adults in 2018 and 3865 adults in 2020 were assessed for knowledge of HPV, its vaccine, its association with OPSCC, and changes in awareness between 2018 and 2020. Statistical significance was set at P < .05.
Most respondents were aware of HPV (2018: 60.8%; 2020: 64.8%) and its vaccine (2018: 60.8%; 2020: 61.6%). A significant decrease in awareness of the association between HPV and cervical cancer was seen between 2018 and 2020 (75.0% vs 70.2%, P = .028). Knowledge of HPV+ OPSCC was poor and did not change over time (2018: 27.0%, 2020: 29.5%). Statistically significant increases in HPV awareness between 2018 and 2020 were found for individuals who reported completing high school as their highest level of education (P = .009), Caucasians (P = .013), males (P = .024), and those making more than $200,000 annually (P = .022).
Knowledge of the association between HPV and OPSCC remained poor despite expanded vaccine eligibility. Public health education on the association may increase awareness for groups likely to benefit from vaccination.
人乳头瘤病毒(HPV)是口咽鳞状细胞癌(OPSCC)风险升高的一个重要驱动因素。2018年,HPV疫苗接种资格扩大到27至45岁的男性和女性。我们评估了2018年至2020年间所有美国成年人对HPV的认识变化、其与OPSCC的关联以及HPV疫苗接种情况,重点关注27至45岁的人群。
横断面调查周期。
健康信息国家趋势调查(HINTS)。
对HINTS进行查询,该调查是对美国成年人具有全国代表性的调查。对2018年的3504名成年人和2020年的3865名成年人进行了HPV知识、HPV疫苗知识、HPV与OPSCC的关联以及2018年至2020年期间认识变化的评估。统计学显著性设定为P < 0.05。
大多数受访者知晓HPV(2018年:60.8%;2020年:64.8%)及其疫苗(2018年:60.8%;2020年:61.6%)。2018年至2020年间,HPV与宫颈癌关联的知晓率显著下降(75.0%对70.2%,P = 0.028)。对HPV阳性OPSCC的了解较少且未随时间变化(2018年:27.0%,2020年:29.5%)。2018年至2020年间,报告最高学历为高中毕业的个体(P = 0.009)、白人(P = 0.013)、男性(P = 0.024)以及年收入超过20万美元的个体(P = 0.022)对HPV的知晓率有统计学显著提高。
尽管疫苗接种资格有所扩大,但对HPV与OPSCC关联的了解仍然较少。关于这种关联的公共卫生教育可能会提高可能从疫苗接种中受益的群体的认识。